Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection
Grant
Overview
Affiliation
Overview
Awarded By
National Institute of Allergy and Infectious Diseases/NIH/DHHS
Total Award Amount
5989971.00
Direct Costs
5017436.00
Sponsor Award Id
HHSN272201600017C
Affiliation
Contributor
David Kimberlin M.D.
Principal Investigator
Edward Acosta Pharm.D.
Investigator
Inmaculada Aban
Investigator
Karen Fowler
Investigator
Richard Whitley M.D.
Investigator
Scott James
Investigator
Suresh Boppana M.D.
Investigator